Details of the Drug Combinations

General Information of This Drug (ID: DMCN61Z)

Drug Name

Interferon beta-1b DMCN61Z

Synonyms

Betaferon (TN); Betaseron (TN)

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Immunomodulatory Agents

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Interferon beta-1b + Lopinavir	DCP0SF9	Lopinavir	Middle East Respiratory Syndrome (MERS)	[2]
Ribavirin + Interferon beta-1b	DC4PUE0	Ribavirin	Coronavirus Disease 2019 (COVID-19)	[3]
Ribavirin + Interferon beta-1b	DCLHAK6	Ribavirin	Coronavirus Disease 2019 (COVID-19)	[3]
------------------------------------------------------------------------------------

References

1	Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
2	ClinicalTrials.gov (NCT02845843) MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
3	ClinicalTrials.gov (NCT04276688) Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment